Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: Analysis of published clinical data

Journal of the Neurological Sciences

Volumn 203-204, Issue , 2002, Pages 147-151

  Amenta, Francesco ^a   Mignini, Fiorenzo ^a   Rabbia, Franco ^b   Tomassoni, Daniele ^a   Veglio, Franco ^b  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Anti hypertensive drugs; Clinical trials; Cognition; Hypertension; Vascular cognitive impairment; Vascular dementia

Indexed keywords

ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLORTALIDONE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FELODIPINE; HYDROCHLOROTHIAZIDE; ISRADIPINE; LISINOPRIL; LOSARTAN; MANIDIPINE; METOPROLOL; NICARDIPINE; NIFEDIPINE; NITRENDIPINE; PERINDOPRIL; PROPRANOLOL; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; DIASTOLIC BLOOD PRESSURE; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ESSENTIAL HYPERTENSION; HUMAN; MINI MENTAL STATE EXAMINATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PULSE PRESSURE; SYSTOLIC HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; CLINICAL TRIALS; COGNITION DISORDERS; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES;

EID: 0037111124     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00281-2     Document Type: Conference Paper

References (53)

1. Rigaud A.S., Hanon O., Bouchacourt P., Forette F. Cerebral complications of hypertension in the elderly. Rev. Med. Int. 22:2000;959-968.
2. In't Veld B.A., Ruitenberg A., Hofman A., Stricker B.H., Breteler M.M.B. Antihypertensive drugs and incidence of dementia: the Rotterdam study. Neurobiol. Aging. 22:2001;407-412.
3. Prince M.J. The treatment of hypertension in older people and its effect on cognitive function. Biomed. Pharmacother. 51:1997;208-212.
4. Kaplan R.C. Treatment of hypertension to prevent stroke: translating evidence into clinical practice. J. Clin. Hypertens. 164:2001;153-156.
5. Harrington F., Saxby B.K., McKeith I.G., Wesnes K., Ford G.A. Cognitive performance in hypertensive and normotensive older subjects. Hypertension. 36:2000;1079-1082.
6. Coté I., Gregoire J.P., Moisan J. Health-related quality-of-life measurement in hypertension. A review of randomised controlled drug trials. PharmacoEconomics. 18:2000;435-450.
7. Farmer M.E., Kittner S.J., Abbott R.D., Wolz M.M., Wolf P.A., White L.R. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study. J. Clin. Epidemiol. 43:1990;475-480.
8. Elias M.F., Wolf P.A., D'agostino R.B., Cobb J., White L.R. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am. J. Epidemiol. 138:1993;353-364.
9. Farmer M.E., White L.R., Abbott R.D.et al. Blood pressure and cognitive performance. The Framingham Study. Am. J. Epidemiol. 126:1987;1103-1114.
10. Kilander L., Nyman H., Boberg M., Hansson L., Lithell H. Hypertension is related to cognitive impairment: a 20-year follow-up of 1999 men. Hypertension. 31:1996;780-786.
11. Launer L.J., Masaki K., Petrovich H., Foley D., Havlik R.J. The association between blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study. JAMA. 274:1995;1846-1851.
12. Applegate W.B., Pressels S., Wittes J.et al. Impact of the treatment of isolated systolic hypertension on behavioral variables: results from the systolic hypertension in the Elderly Program. Arch. Intern. Med. 154:1994;2154-2160.
13. Goldstein G., Materson B.J., Cushman W.C., Reda D.J., Freis E.D., Ramirez E.A.et al. Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Hypertension. 15:1990;361-369.
14. Cushman W.C., Khatri I., Materson B.J., Reda D.J., Freis E.D., Goldstein G.et al. Treatment of hypertension in elderly. Response of isolated systolic hypertension to various doses of hydrochlorothiazide: results of a Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch. Intern. Med. 151:1991;1954-1960.
15. Starr J.M., Whalley L.J., Deary I.J. The effect of antihypertensive treatment on cognitive function: results from the HOPE Study. J. Am. Geriatr. Soc. 44:1996;411-415.
16. Forette F., Seux M., Staessen J., Thijs L., Birkcnhager W. Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 352:1998;1347-1351.
17. Guo Z., Fratiglioni L., Winblad B., Vitanen M. Blood pressure and performance on the Mini-Mental State. Examination in the very old: cross-sectional and longitudinal data from the Kunsholmen Project. Am. J. Epidemiol. 145:1997;1106-1113.
18. Skoog I., Lernfelt B., Landahl S., Palmertz B., Andreasson L.A., Nilsson L.et al. Fifteen-year longitudinal study of blood pressure and dementia. Lancet. 347:1996;1141-1145.
19. Solomon S., Hotchkiss E., Saravay S.M., Bayer C., Ramsey P., Blum R.S. Impairment of memory function by antihypertensive medication. Arch. Gen. Psychiatry. 40:1983;1109-1112.
20. Lasser N.L., Nash J., Lasser V.I., Hamill S.J., Batey D.M. Effects of antihypertensive therapy on blood pressure control, cognition and reactivity. A placebo-controlled comparison of prazosin, propranolol and hydrochlorothiazide. Am. J. Med. 23:1989;98-103.
21. Schmidt G.R., Schuna A.A., Goodfriend T.L. Transdermal clonidine compared with hydrochlorothiazide as monotherapy in elderly hypertensive males. J. Clin. Pharmacol. 29:1989;133-139.
22. Bird A.S., Blizard R.A., Mann A.H. Treating hypertension in the older person: an evaluation of the association of blood pressure level and its reduction with cognitive performance. J. Hypertens. 8:1990;147-152.
23. McCorvey E. Jr., Wright J.T. Jr., Culbert J.P., McKenney J.M., Proctor J.D., Annett M.P. Effect of hydrochlorothiazide, enalapril, and propranolol on quality of life and cognitive and motor function in hypertensive patients. Clin. Pharmacokinet. 12:1993;300-305.
24. Vanmolkot F.H., de Hoon J.N., van de Ven L.L., Van Bortel L.M. Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide. J. Hum. Hypertens. 13:1999;559-563.
25. Ogihara T., Kuramoto K. Effect of long-term treatment with antihypertensive drugs on quality of life of elderly patients with hypertension: a double-blind comparative study between a calcium antagonist and a diuretic. NICS-EH Study Group. National International Cooperative Study in Elderly Hypertensives. Hypertens. Res. 23:2000;33-37.
26. Nikolaus T., Sommer N., Becker C. Treatment of arterial hypertension with diuretic, beta- and calcium channel blockers in old patients. Z. Gerontol. Geriatr. 33:2000;427-432.
27. Fletcher A.E., Bulpitt C.J., Chase D.M.et al. Quality of life with three antihypertensive treatments: cilazapril, atenolol, nifedipine. Hypertension. 19:1992;499-507.
28. Madden D.J., Blumenthal J.A., Ekelund L.G., Krantz D.S., Light K.C., McKee D.C. Memory performance by mild hypertensive following beta-adrenergic blockade. Psychopharmacology. 89:1986;20-24.
29. Madden D.J., Blumenthal J.A., Ekelund L.G. Effects of beta-blockade and exercise on cardiovascular and cognitive functioning. Hypertension. 11:1988;470-476.
30. Steufert S., DePadova A., McGlynn T., Pogash R., Piasecki M. Impact of beta-blockade on complex cognitive functioning. Am. Heart J. 116:1988;311-315.
31. Kostis J.B., Rosen R.C., Holzer B.C., Randolph C., Taska L.S., Miller M.H. CNS side effects of centrally-active antihypertensive agents: a prospective, placebo-controlled study of sleep, mood state, and cognitive and sexual function in hypertensive males. Psychopharmacology. 102:1990;163-170.
32. Steiner S.S., Friedhoff A.J., Wilson B.L., Wecker J.R., Santo J.P. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol. J. Hum. Hypertens. 4:1990;217-225.
33. Palac D.M., Cornish R., McDonald W.et al. Cognitive function in hypertensives treated with atenolol or propranolol. J. Gen. Intern. Med. 5:1990;310-318.
34. Frimodt-Moeller J., Poulsen D.L., Kornerup H.J., Bech P. Quality of life, side effects and efficacy of lisinopril compared with metoprolol in patients with mild to moderate essential hypertension. J. Hum. Hypertens. 5:1991;215-221.
35. Ameiling E.H., de Korte D.F., Man in't Veld A. Impact of diagnosis and treatment of hypertension on quality of life: a double-blind, randomized, placebo-controlled, cross-over study of betaxolol. J. Cardiovasc. Pharmacol. 18:1991;752-760.
36. Croog S.H., Elias M.F., Colton T., Baume R.M., Leiblum S.R., Jenkins C.D.et al. Effects of antihypertensive medications on quality of life in elderly hypertensive women. Am. J. Hypertens. 7:1994;329-339.
37. Prince M.J., Bird A.S., Bizard R.A., Mann A.H. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults. Br. Med. J. 312:1996;801-805.
38. Maxwell C.J., Hogan D.B., Ebly E.M. Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. CMAJ. 61:1999;501-506.
39. Bulpitt C.J., Connor M., Schulte M., Fletcher A.E. Bisoprolol and nifedipine retard in elderly hypertensive patients: effect on quality of life. J. Hum. Hypertens. 14:2000;205-212.
40. Perez-Stable E.J., Halliday R., Gardiner P.S., Baron R.B., Hauck W.W., Acree M.et al. The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension. Am. J. Med. 108:2000;359-365.
41. Tedesco M.A., Ratti G., Mannella S., Manzo G., Grieco M., Rainone A.C.et al. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. Am. J. Hypertens. 12:1999;1130-1134.
42. Breckenridge A. Angiotensin converting enzyme inhibitors and quality of life. Am. J. Hypertens. 4:1991;79S-82S.
43. Leonetti G., Salvetti A. Effects of cilazapril and nitrendipine on blood pressure mood, sleep, and cognitive function in elderly hypertensive patients: an Italian multicenter study. J. Cardiovasc. Pharmacol. 24:1994;S73-S77.
44. PROGRESS Management Committee PROGRESS: Perindropil Protection Against Recurrent Stroke Study: status in March. J. Hum. Hypertens. 12:1998;627-629.
45. Louis W.J., Mander A.G., Dawson M., O'Callaghan C., Conway E.L. Use of computerized neuropsychological test (CANTAB) to assess cognitive effects of antihypertensive drugs in the elderly. Cambridge Neuropsychological Test Automated Battery. J. Hypertens. 17:1999;1813-1819.
46. Scarzella L., Bergamasco B. Nicardipine in the therapy of arterial hypertension in elderly patients with the psycho-organic syndrome. Report on the results of the clinical study. Clin. Ter. 130:1989;171-178.
47. Palmer A., Fletcher A., Hamilton G., Muriss S., Bulpitt C. A comparison of verapamil and nifedipine on quality of life. Br. J. Clin. Pharmacol. 30:1990;365-370.
48. Ogihara T., Nakagawa M., Ischikawa H., Mikami H., Takeda K., Nonaka H.et al. Effect of manidipine, a novel calcium channel blocker, on quality of life in hypertensive patients. Blood Press., Suppl. 3:1992;135-139.
49. Skinner N.H., Futterman A., Morrissette D.et al. Atenolol compared with nifedipine: effect on cognitive function and mood in elderly hypertensive patients. Ann. Intern. Med. 116:1992;615-623.
50. Neutel J.M., Smith D.H., Lefkowitz M.P., Cargo P., Alemayehu D., Weber M.A. Hypertension in the elderly: 24 h ambulatory blood pressure results from a placebo-controlled trial. J. Hum. Hypertens. 9:1995;723-727.
51. Molto J.M., Falip R., Martin R., Insa R., Pastor I., Matias-Guiu J. Comparative study of nicardipine versus placebo in the prevention of cognitive deterioration in patients with transient ischemic attack. Rev. Neurol. 23:1995;54-58.
52. Gonzales-Gonzales J.A., Lozano R. A study of tolerability and effectiveness of nicardipine retard in cognitive deterioration of vascular origin. Rev. Neurol. 30:2000;719-728.
53. Lehrl S., Grassel E., Eicke C. Effectiveness of felodipine in hypertensive patients with mild cerebral cognition disorders in a randomized double-blind study. Dtsch. Med. Wochenschr. 125:2000;1350-1355.